Both in Pharmaceuticals
Supernus Pharmaceuticals vs Disc Medicine
Over the past year SUPN returned −7.6% and IRON returned +1.2%; their daily moves had a correlation of 0.11.
SUPN −7.6% IRON +1.2%Growth of $1, one year, split-adjusted
| Metric | SUPN | IRON |
|---|---|---|
| Price | $43.97 | $65.87 |
| Market cap | $2.56B | $2.53B |
| Today | −1.41% | +1.46% |
| 1 month | +0.5% | −17.7% |
| 6 months | −10.9% | +8.4% |
| Year to date | −11.5% | −17.1% |
| 1 year | −6.5% | +0.5% |
| Revenue growth (YoY) | +32.4% | — |
| Gross margin | 84.6% | — |
| Net margin | −26.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.1× | — |
| Net cash | $372.1M | $658.4M |
| Dividend yield | — | — |
| Volatility (60d) | 35.9% | 33.9% |
| Short % of float | 9.0% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).